| Literature DB >> 31056774 |
Murali Krishna1,2, Steven Jones3, Michelle Maden4, Bharath Du1, Ramya Mc2, Kalyanaraman Kumaran2,5, Samuel Christraprasad Karat2,6, Caroline H D Fall5.
Abstract
INTRODUCTION: Recent evidence suggests that growth restriction in utero may lead to neurocognitive disorders in late life, either through impaired brain development or adverse metabolic programming.Entities:
Keywords: DOHaD; birth weight; cognition; systematic review
Mesh:
Year: 2019 PMID: 31056774 PMCID: PMC6771720 DOI: 10.1002/gps.5138
Source DB: PubMed Journal: Int J Geriatr Psychiatry ISSN: 0885-6230 Impact factor: 3.485
Figure 1Flow diagram illustrating the process of selection of eligible studies for this systematic review
Key characteristics of the studies included in this systematic review
| First author, Year, and Country | Population and Setting | Study Design | Sample Size, Gender, and Age | Exclusion Criteria | Early Life Exposures | Cognitive Outcomes |
|---|---|---|---|---|---|---|
| Martyn 1996 UK | Men and women born in Hertfordshire, Sheffield, or Preston between 1920 and 1943 | Longitudinal follow‐up of a birth cohort. |
N = 1576 | Those born before 38 weeks of gestation. | Birth weight, length, head circumference, gestational age, maternal age, parity, and paternal occupation | Alice Heim intelligence test and Mill Hill Vocabulary test |
| Raikkonen 2013 Finland | Men born Helsinki between 1934 and 1944 and performed compulsory military service. | Longitudinal follow‐up of the Helsinki birth cohort. |
N = 931 (0% F) | Those not living in Helsinki. | Birth weight, length, head circumference, gestational age, maternal age, parity, and height | Finnish Defense Forces basic Intellectual Ability Test |
| Shenkin 2007 UK | Men and women born in one hospital in Edinburgh UK between 1921 and 1926 | Longitudinal follow‐up of a birth cohort. |
N = 130 (71% F) | Dementia and deafness. | Birth weight, length, head circumference, gestational age, maternal age, parity, and height |
Controlled Word Association Test, Murray House Test, Raven's Matrices Test, and |
| Gale 2003 UK | Men and women born in Jessop Hospital for Women in Sheffield. | Longitudinal follow‐up of a stratified sample of a birth cohort. |
N = 215 (46% F) | Dementia or deafness | Birth weight, length, head circumference, gestational age, and parental occupation | Alice Heim Intelligence Test and Weschler logical memory test |
| Costa et al 2011 USA | Men and women from Minneapolis and Washington. | Longitudinal follow‐up of a community cohort. |
N = 6785 (56% F) | CHD, CVA mental disorders, prematurity, and non white. | Birth weight by recall and non‐hospital records. |
Delayed Word Recall test, |
| Skogen 2013 Norway | Men and women from Bergen born between 1925 and 1927 | Longitudinal follow‐up of a birth cohort. |
N = 346 (55% F) | Non‐reported | Birth weight, length, head circumference, maternal age and parity, parental occupation | Kendrik Object Learning test, Trail making test, Digit Symbol Test, Block Design, and Controlled Word Association Test. |
| Hyvarinen 2009 Finland | Men and women living in Helsinki and matched to birth records. | Longitudinal follow‐up of a randomly selected subsample in a birth cohort. |
N = 1243 (53% F) | Major physical disabilities and poor vision. | Birth weight | Beck's Depression Inventory Battery of cognitive tests (for reaction time, attention, working memory, and associate learning) |
| Zhang 2009 China | Men and women born in Beijing between 1921 and 1954, and matched to birth records. | Retrospective birth cohort, cross‐sectional design |
N = 2062 (48% F) | None reported | Birth weight, length, head circumference, maternal age and parity, gestational age, and parental occupation at birth |
Fluid object memory test Verbal fluency |
| de Rooij 2010 Netherlands | Men and women born between 1944 and 1945 (from the Dutch Famine Birth Cohort) | Longitudinal follow‐up of a birth cohort. |
N = 737 (53% F) | Mental disorders | Birth weight, head circumference, gestational age, placental area, and occupation of head of the household | Alice Heim test, Stroop test, Paragraph Encoding and Recall Mirror drawing test |
| Muller 2014 Iceland | Men and women from Reykjavik born between 1907 and 1935 | Longitudinal follow‐up of a randomly selected subjects from a birth cohort. |
N = 1254 (57% F) | Dementia and prematurity | Birth weight and length |
California Verbal Learning Test |
| Ericson 2010 US | Women living in Rancho Bernado | Cross‐sectional |
N = 292 | Not reported | Birth weight (self reported) |
Blessed Dementia Scale, |
Summary of cognitive function tests, effect sizes, and risk of bias in studies included in the systematic review
|
Study (yr) | Unadjusted correlation | Adjusted correlation | Confounders | Risk of Bias | |||||
|---|---|---|---|---|---|---|---|---|---|
| Cognitive test | Coefficient | SE | p | Coefficient | SE |
| |||
| Zhang et al (2009) Ponderal Index (kg/m3) | Immediate Recall | NR | NR | NR | .50 | Gestational age, parity, and paternal occupation at birth; drinking milk during childhood; age, sex, cardiometabolic risk factors, socioeconomic position, and occupation in adult life. | Low | ||
| Delayed Recall | NR | NR | NR | .77 | |||||
| Cumulative score | OR = 1.5 | NR | 0.02 | OR = 1.26 | NR | .30 | |||
| de Rooij et al.(2010) | Alice Heim (reaction time) |
| ns | NR | NR | NR | No adjustments were made. Spearman correlation coefficients were reported for birth weight and cognitive outcomes. | Medium | |
| Alice Heim score |
| ns | NR | NR | NR | ||||
| Stroop test |
| ns | NR | NR | NR | ||||
| Stroop score |
| ns | NR | NR | NR | ||||
| Memory Immediate recall |
| ns | NR | NR | NR | ||||
| retrieval |
| ns | NR | NR | NR | ||||
| Mirror errors |
| ns | NR | NR | NR | ||||
| Mirror rounds |
| ns | NR | NR | NR | ||||
| Mirror errors per rounds |
| ns | NR | NR | NR | ||||
| Costa et al (2011) Birth weight (gms) | Word fluency | NR |
| 0.3 | .004 | Age, sex, education, race, social class, education, smoking, alcohol, body mass index (BMI), and self‐reported cardiometabolic risk factors (diabetes, hypertension, LDL, and HDL cholesterol), and history of stroke. | High | ||
| Delayed word recall | NR |
| 0.03 | ns | |||||
| Digit symbol | NR |
| 0.25 | ns | |||||
| Martyn et al. (1993) Head circumference (inch) | Alice Heim Test | NR | NR | NR | .008 | Social class at birth, age, sex and for individual datasets. | Medium | ||
| Decline | NR | NR | NR | .85 | |||||
| Hyvarinen et al (2009) Birth weight (kgs) | Divided attention | NR |
| 1.38 | .005 |
Gestational age, sex, age, and education |
| ||
| Association learning | NR |
| 0.71 | .04 | |||||
| Association learning | NR | NR | NR | ns | |||||
| Simple reaction time | NR | NR | NR | ns | |||||
| Choice reaction time | NR | NR | NR | ns | |||||
| Working memory hit rate | NR | NR | NR | ns | |||||
| Working memory reaction time | NR | NR | NR | ns | |||||
| Raikkonen et al. (2013) Birth weight (SD) | IQ (Finnish Defense Forces) |
| 0.51 | 0.04 |
| 0.64 | .04 | Gestational age and parity at birth; breastfeeding in childhood; education, social class, height, and history of heart disease and stroke |
|
| Decline |
| 0.04 | 0.04 |
| 0.04 | .06 | |||
| Erickson et al (2010) Birth Weight (lbs) | Buschke total | NR |
| .77 | Age and education | Medium | |||
| Buschke LTM | NR |
| .83 | ||||||
| Buschke STM | NR |
| .97 | ||||||
| Heaton visual copying | NR |
| .63 | ||||||
| Heaton visual LTM | NR |
| .99 | ||||||
| Heaton visual STM | NR |
| .22 | ||||||
| MMSE total | NR |
| .57 | ||||||
| Serial 7's | NR |
| .04 | ||||||
| world backward | NR |
| .89 | ||||||
| Trails B | NR |
| .18 | ||||||
| Category fluency | NR |
| .59 | ||||||
| Blessed | NR |
| .16 | ||||||
| Skogen et al (2013) Birth weight (kgs) | Mini Mental State Examination |
| 0.09 | ns |
| 0.09 | ns | Age and sex | Medium |
| Digit symbol |
| 0.44 | ns |
| 0.45 | ns | |||
| Kendrick |
| 0.79 | ns |
| 0.78 | ns | |||
| Object learning COWAT |
| 0.55 | ns |
| 0.55 | ns | |||
| Trail making A |
| 2.94 | ns |
| 2.97 | ns | |||
| Block Design |
| 0.21 | ns |
| 0.21 | ns | |||
| Composite score |
| 0.1 | ns |
| 0.1 | ns | |||
| Muller et al (2014) | Memory | NR | NR | Age and sex | Medium | ||||
| Processing speed | NR |
| NR | .008 | |||||
| Executive function | NR |
| NR | .04 | |||||
| Gale et al (2003) Head circumference at birth (cms) | Alice Heim Intelligence score | NR | NR | NR | .38 | Social class at birth, age, sex, education, history of cerebrovascular disease and Nottingham Health Profile emotion subscale | Medium | ||
| Weschler Immediate Recall | NR | NR | NR | .75 | |||||
| Weschler Delayed Recall | NR | NR | NR | .74 | |||||
| Decline on Alice Heim Intelligence score | NR | NR | NR | .94 | |||||
| Shenkin et al (2009) Birth weight (gms) | Raven's Progressive Matrices |
| ns | ns |
| ns | ns |
Gestational age and parity at birth | Low |
| Moray House test |
| ns | ns |
| ns | ns | |||
| Test no 12 |
| ns | ns |
| ns | ns | |||
| Verbal Fluency |
| ns | ns |
| ns | ns | |||
| g (General Intelligence) |
| ns | ns |
| 0.27 | .27 | |||
| National Adult Reading Test |
| ns | ns |
| 0.19 | .19 | |||
| g corrected for National Adult Reading Test |
| ns | ns |
| 0.19 0.63 | .19.63 | |||
Abbreviations: β = effect size from regression analyses; ρ, correlation coefficient; NR, not reported; ns = not significant but values not provided; OR, odds ratio; r, rho.
Odds ratio for lower cognition defined as cumulative score lower than 10 percentile.
values only for those exposed to famine in utero.
values for those with low education only.
| Item No | Recommendation | Page Number | |
|---|---|---|---|
| Title and abstract | 1 | (a) Indicate the study's design with a commonly used term in the title or the abstract. | 1 |
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found. | 1 | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported. | 1 |
| Objectives | 3 | State specific objectives, including any pre‐specified hypotheses. | 1 |
| Methods | |||
| Study design | 4 | Present key elements of study design early in the paper. | 1‐2 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow‐up, and data collection. | 2 |
| Participants | 6 |
(a) | 2 |
|
(b) | |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. | 2‐3 |
| Data sources/measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. | 2‐3 |
| Bias | 9 | Describe any efforts to address potential sources of bias. | 5 |
| Study size | 10 | Explain how the study size was arrived at. | no |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. | 3‐4 |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding. | 2‐4 |
| (b) Describe any methods used to examine subgroups and interactions. | 2‐4 | ||
| (c) Explain how missing data were addressed. | no | ||
|
(d) | |||
| ( | no | ||
| Results | |||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—eg, numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow‐up, and analysed. | 3 |
| (b) Give reasons for non‐participation at each stage. | no | ||
| (c) Consider use of a flow diagram. | no | ||
| Descriptive data | 14* | (a) Give characteristics of study participants (eg, demographic, clinical, social) and information on exposures and potential confounders. | 3 |
| (b) Indicate number of participants with missing data for each variable of interest. | no | ||
| (c) | 2‐3 | ||
| Outcome data | 15* |
| 2 |
|
| |||
|
| |||
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder‐adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included. | 4 |
| (b) Report category boundaries when continuous variables were categorised | |||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. | |||
| Other analyses | 17 | Report other analyses done—eg, analyses of subgroups and interactions and sensitivity analyses. | 4 |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives. | 3‐4 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. | 4 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. | 4 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results. | 4 |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 4 |
| Title and abstract | 1 | (a) Indicate the study's design with a commonly used term in the title or the abstract. | 1 |
| (b) Provide in the abstract an informative and balanced summary of what was done and what was found. | 1 | ||
| Introduction | |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported. | 2 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses. | 2 |
| Methods | |||
| Study design | 4 | Present key elements of study design early in the paper. | 2 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow‐up, and data collection. | 2 |
| Participants | 6 |
(a) | 2 |
|
(b) | |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. | 3 |
| Data sources/measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. | 3 |
| Bias | 9 | Describe any efforts to address potential sources of bias. | 2‐3 |
| Study size | 10 | Explain how the study size was arrived at. | no |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. | 3 |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding. | 3‐5 |
| (b) Describe any methods used to examine subgroups and interactions. | 5 | ||
| (c) Explain how missing data were addressed. | no | ||
|
(d) | no | ||
| ( | 5 | ||
| Results | |||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—eg, numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow‐up, and analysed. | 2 |
| (b) Give reasons for non‐participation at each stage. | 2 | ||
| (c) Consider use of a flow diagram. | no | ||
| Descriptive data | 14* | (a) Give characteristics of study participants (eg, demographic, clinical, social) and information on exposures and potential confounders. | 3 |
| (b) Indicate number of participants with missing data for each variable of interest. | 3 | ||
| (c) | 3 | ||
| Outcome data | 15* |
| 2 |
|
| |||
|
| |||
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder‐adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included. | 3‐5 |
| (b) Report category boundaries when continuous variables were categorised. | |||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. | |||
| Other analyses | 17 | Report other analyses done—eg, analyses of subgroups and interactions and sensitivity analyses. | 3‐5 |
| Discussion | |||
| Key results | 18 | Summarise key results with reference to study objectives. | 6 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. | 6 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. | 6 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results. | no |
| Other information | |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based. | 7 |